Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review
作者： Xinghua Xu , Chigang Du , Qingmei Zheng , Lina Peng , Yuanyuan Sun
关键词:
摘要: Background Most women with polycystic ovary syndrome (PCOS) have insulin resistance, hyperinsulinemia, and elevated serum IL-6 levels. These levels may links resistance hyperandrogenism. Metformin beneficial effects on the chronic low-grade inflammatory background associated PCOS.
biomedcentral.com
springer.com
core.ac.uk
sci-hub.se 参考文章(21)
Xinghua Xu, Yuhua Shi, Yuqian Cui, Jinlong Ma, Li Che, Zi-Jiang Chen, Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes Clinical Endocrinology. ,vol. 76, pp. 425- 430 ,(2012) , 10.1111/J.1365-2265.2011.04194.X
Yue-Shan Lin, Shaw-Jenq Tsai, Ming-Wei Lin, Cheng-Ta Yang, Mei-Feng Huang, Meng-Hsing Wu, Interleukin-6 as an Early Chronic Inflammatory Marker in Polycystic Ovary Syndrome with Insulin Receptor Substrate-2 Polymorphism American Journal of Reproductive Immunology. ,vol. 66, pp. 527- 533 ,(2011) , 10.1111/J.1600-0897.2011.01059.X
Frank González, Chang Ling Sia, Frank Z. Stanczyk, Hilary E. Blair, Michelle E. Krupa, Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome. Endocrine. ,vol. 42, pp. 726- 735 ,(2012) , 10.1007/S12020-012-9728-6
Héctor F. Escobar-Morreale, Rosa M. Calvo, Gemma Villuendas, José Sancho, José L. San Millán, Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obesity Research. ,vol. 11, pp. 987- 996 ,(2003) , 10.1038/OBY.2003.136
Joanna Jakubowska, Anna Bohdanowicz-Pawlak, Andrzej Milewicz, Jadwiga Szymczak, Grażyna Bednarek-Tupikowska, Marek Demissie, Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment. Gynecological Endocrinology. ,vol. 24, pp. 378- 384 ,(2008) , 10.1080/09513590802128968
Susan Sirmans, Kirsten Pate, Epidemiology, diagnosis, and management of polycystic ovary syndrome Clinical Epidemiology. ,vol. 6, pp. 1- 13 ,(2013) , 10.2147/CLEP.S37559
Theodore P. Ciaraldi, Vanita Aroda, Sunder R. Mudaliar, Robert R. Henry, Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment. Metabolism-clinical and Experimental. ,vol. 62, pp. 1587- 1596 ,(2013) , 10.1016/J.METABOL.2013.07.004
R AZZIZ, Diagnostic criteria for polycystic ovary syndrome: A reappraisal Fertility and Sterility. ,vol. 83, pp. 1343- 1346 ,(2005) , 10.1016/J.FERTNSTERT.2005.01.085
Venkat Reddy Tumu, Suresh Govatati, Praveen Guruvaiah, Mamata Deenadayal, Sisinthy Shivaji, Manjula Bhanoori, An interleukin-6 gene promoter polymorphism is associated with polycystic ovary syndrome in South Indian women Journal of Assisted Reproduction and Genetics. ,vol. 30, pp. 1541- 1546 ,(2013) , 10.1007/S10815-013-0111-1
Miriam Ojeda-Ojeda, Mora Murri, Maria Insenser, Hector Escobar-Morreale, Mediators of Low-Grade Chronic Inflammation in Polycystic Ovary Syndrome (PCOS) Current Pharmaceutical Design. ,vol. 19, pp. 5775- 5791 ,(2013) , 10.2174/1381612811319320012